Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan.

ABSTRACT:

Purpose

To clarify recent trends in the use of intravitreal injections of anti-vascular endothelial growth factor (VEGF) in Japan.

Study design

Retrospective cohort study.

Methods

We used the DeSC database, a large-scale claims database for Japan, for entries between April 2014 and March 2021. We counted the number of anti-VEGF drug injections (aflibercept, ranibizumab, brolucizumab, and pegaptanib) administered every year, calculated the sex- and age-adjusted injection rates, and stratified these rates according to sex, age categories, anti-VEGF drugs, and diagnoses. We also calculated the number of injections administered within one year after the first injection according to the diagnoses.

Results

In total, 164,451 cases of anti-VEGF injections were identifi

SUBMITTER: Hashimoto Y 

PROVIDER: S-EPMC9742668 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature